NCT03183375.

Trial name or title	The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan
Methods	Open‐label RCT
Participants	People with transfusion‐ and non‐transfusion‐dependent beta‐thalassaemia
Interventions	Hydroxyurea (hydroxycarbamide)
Outcomes	Number of participants who become responder (become transfusion independent or maintain a mean haemoglobin level or result in increase in haemoglobin by 1 ‐ 2 g/dL) or partial responder (transfusion need decreases of at least 50% as compared to baseline)
Starting date	20 June 2017
Contact information	muddasirsaqib@yahoo.com
Notes